Responses
Late-breaking abstracts
Immunotherapy toxicities
856 Preliminary review of Diabetes Mellitus incidence in patients treated with immune checkpoint inhibitors (ICI) therapy – Roswell Park Comprehensive Cancer Center (RPCCC) experience
Compose a Response to This Article
Other responses
No responses have been published for this article.